Global Type-1 Diabetes Treatment Market Research Report 2023

Report ID: 2005964 | Published Date: Oct 2024 | No. of Page: 91 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Rapid-Acting Insulin
        1.2.3 Short-Acting Insulin
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Type-1 Diabetes Treatment Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals & Clinics
        1.3.3 Academic & Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Type-1 Diabetes Treatment Market Perspective (2018-2029)
    2.2 Type-1 Diabetes Treatment Growth Trends by Region
        2.2.1 Global Type-1 Diabetes Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Type-1 Diabetes Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Type-1 Diabetes Treatment Market Dynamics
        2.3.1 Type-1 Diabetes Treatment Industry Trends
        2.3.2 Type-1 Diabetes Treatment Market Drivers
        2.3.3 Type-1 Diabetes Treatment Market Challenges
        2.3.4 Type-1 Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Type-1 Diabetes Treatment Players by Revenue
        3.1.1 Global Top Type-1 Diabetes Treatment Players by Revenue (2018-2023)
        3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Type-1 Diabetes Treatment Revenue
    3.4 Global Type-1 Diabetes Treatment Market Concentration Ratio
        3.4.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2022
    3.5 Type-1 Diabetes Treatment Key Players Head office and Area Served
    3.6 Key Players Type-1 Diabetes Treatment Product Solution and Service
    3.7 Date of Enter into Type-1 Diabetes Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Type-1 Diabetes Treatment Breakdown Data by Type
    4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2024-2029)
5 Type-1 Diabetes Treatment Breakdown Data by Application
    5.1 Global Type-1 Diabetes Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Type-1 Diabetes Treatment Market Size (2018-2029)
    6.2 North America Type-1 Diabetes Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Type-1 Diabetes Treatment Market Size by Country (2018-2023)
    6.4 North America Type-1 Diabetes Treatment Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Type-1 Diabetes Treatment Market Size (2018-2029)
    7.2 Europe Type-1 Diabetes Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Type-1 Diabetes Treatment Market Size by Country (2018-2023)
    7.4 Europe Type-1 Diabetes Treatment Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Type-1 Diabetes Treatment Market Size (2018-2029)
    8.2 Asia-Pacific Type-1 Diabetes Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2018-2023)
    8.4 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Type-1 Diabetes Treatment Market Size (2018-2029)
    9.2 Latin America Type-1 Diabetes Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Type-1 Diabetes Treatment Market Size by Country (2018-2023)
    9.4 Latin America Type-1 Diabetes Treatment Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Type-1 Diabetes Treatment Market Size (2018-2029)
    10.2 Middle East & Africa Type-1 Diabetes Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2018-2023)
    10.4 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Astellas Pharma
        11.1.1 Astellas Pharma Company Detail
        11.1.2 Astellas Pharma Business Overview
        11.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
        11.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.1.5 Astellas Pharma Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Type-1 Diabetes Treatment Introduction
        11.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.2.5 Merck Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Detail
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
        11.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.3.5 Eli Lilly Recent Development
    11.4 Novo Nordisk
        11.4.1 Novo Nordisk Company Detail
        11.4.2 Novo Nordisk Business Overview
        11.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
        11.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.4.5 Novo Nordisk Recent Development
    11.5 Sanofi
        11.5.1 Sanofi Company Detail
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi Type-1 Diabetes Treatment Introduction
        11.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.5.5 Sanofi Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Detail
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
        11.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.6.5 AstraZeneca Recent Development
    11.7 Boehringer Ingelheim GmbH
        11.7.1 Boehringer Ingelheim GmbH Company Detail
        11.7.2 Boehringer Ingelheim GmbH Business Overview
        11.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
        11.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.7.5 Boehringer Ingelheim GmbH Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Type-1 Diabetes Treatment Introduction
        11.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.8.5 Novartis Recent Development
    11.9 Pfizer Inc.
        11.9.1 Pfizer Inc. Company Detail
        11.9.2 Pfizer Inc. Business Overview
        11.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
        11.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.9.5 Pfizer Inc. Recent Development
    11.10 Abbott Laboratories
        11.10.1 Abbott Laboratories Company Detail
        11.10.2 Abbott Laboratories Business Overview
        11.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
        11.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.10.5 Abbott Laboratories Recent Development
    11.11 Mannkind Corporation
        11.11.1 Mannkind Corporation Company Detail
        11.11.2 Mannkind Corporation Business Overview
        11.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
        11.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.11.5 Mannkind Corporation Recent Development
    11.12 Braun Melsungen AG
        11.12.1 Braun Melsungen AG Company Detail
        11.12.2 Braun Melsungen AG Business Overview
        11.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
        11.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.12.5 Braun Melsungen AG Recent Development
    11.13 Macrogenics, Inc.
        11.13.1 Macrogenics, Inc. Company Detail
        11.13.2 Macrogenics, Inc. Business Overview
        11.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
        11.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023)
        11.13.5 Macrogenics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Rapid-Acting Insulin
    Table 3. Key Players of Short-Acting Insulin
    Table 4. Key Players of Others
    Table 5. Global Type-1 Diabetes Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Type-1 Diabetes Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Type-1 Diabetes Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Type-1 Diabetes Treatment Market Share by Region (2018-2023)
    Table 9. Global Type-1 Diabetes Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Type-1 Diabetes Treatment Market Share by Region (2024-2029)
    Table 11. Type-1 Diabetes Treatment Market Trends
    Table 12. Type-1 Diabetes Treatment Market Drivers
    Table 13. Type-1 Diabetes Treatment Market Challenges
    Table 14. Type-1 Diabetes Treatment Market Restraints
    Table 15. Global Type-1 Diabetes Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Type-1 Diabetes Treatment Market Share by Players (2018-2023)
    Table 17. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2022)
    Table 18. Ranking of Global Top Type-1 Diabetes Treatment Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Type-1 Diabetes Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Type-1 Diabetes Treatment Product Solution and Service
    Table 22. Date of Enter into Type-1 Diabetes Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Type-1 Diabetes Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2018-2023)
    Table 26. Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2024-2029)
    Table 28. Global Type-1 Diabetes Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2018-2023)
    Table 30. Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2024-2029)
    Table 32. North America Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Type-1 Diabetes Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Type-1 Diabetes Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Type-1 Diabetes Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Type-1 Diabetes Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Astellas Pharma Company Detail
    Table 48. Astellas Pharma Business Overview
    Table 49. Astellas Pharma Type-1 Diabetes Treatment Product
    Table 50. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 51. Astellas Pharma Recent Development
    Table 52. Merck Company Detail
    Table 53. Merck Business Overview
    Table 54. Merck Type-1 Diabetes Treatment Product
    Table 55. Merck Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 56. Merck Recent Development
    Table 57. Eli Lilly Company Detail
    Table 58. Eli Lilly Business Overview
    Table 59. Eli Lilly Type-1 Diabetes Treatment Product
    Table 60. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 61. Eli Lilly Recent Development
    Table 62. Novo Nordisk Company Detail
    Table 63. Novo Nordisk Business Overview
    Table 64. Novo Nordisk Type-1 Diabetes Treatment Product
    Table 65. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 66. Novo Nordisk Recent Development
    Table 67. Sanofi Company Detail
    Table 68. Sanofi Business Overview
    Table 69. Sanofi Type-1 Diabetes Treatment Product
    Table 70. Sanofi Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 71. Sanofi Recent Development
    Table 72. AstraZeneca Company Detail
    Table 73. AstraZeneca Business Overview
    Table 74. AstraZeneca Type-1 Diabetes Treatment Product
    Table 75. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 76. AstraZeneca Recent Development
    Table 77. Boehringer Ingelheim GmbH Company Detail
    Table 78. Boehringer Ingelheim GmbH Business Overview
    Table 79. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product
    Table 80. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 81. Boehringer Ingelheim GmbH Recent Development
    Table 82. Novartis Company Detail
    Table 83. Novartis Business Overview
    Table 84. Novartis Type-1 Diabetes Treatment Product
    Table 85. Novartis Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 86. Novartis Recent Development
    Table 87. Pfizer Inc. Company Detail
    Table 88. Pfizer Inc. Business Overview
    Table 89. Pfizer Inc. Type-1 Diabetes Treatment Product
    Table 90. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 91. Pfizer Inc. Recent Development
    Table 92. Abbott Laboratories Company Detail
    Table 93. Abbott Laboratories Business Overview
    Table 94. Abbott Laboratories Type-1 Diabetes Treatment Product
    Table 95. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 96. Abbott Laboratories Recent Development
    Table 97. Mannkind Corporation Company Detail
    Table 98. Mannkind Corporation Business Overview
    Table 99. Mannkind Corporation Type-1 Diabetes Treatment Product
    Table 100. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 101. Mannkind Corporation Recent Development
    Table 102. Braun Melsungen AG Company Detail
    Table 103. Braun Melsungen AG Business Overview
    Table 104. Braun Melsungen AG Type-1 Diabetes Treatment Product
    Table 105. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 106. Braun Melsungen AG Recent Development
    Table 107. Macrogenics, Inc. Company Detail
    Table 108. Macrogenics, Inc. Business Overview
    Table 109. Macrogenics, Inc. Type-1 Diabetes Treatment Product
    Table 110. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
    Table 111. Macrogenics, Inc. Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Type-1 Diabetes Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Type-1 Diabetes Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Rapid-Acting Insulin Features
    Figure 4. Short-Acting Insulin Features
    Figure 5. Others Features
    Figure 6. Global Type-1 Diabetes Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Type-1 Diabetes Treatment Market Share by Application: 2022 VS 2029
    Figure 8. Hospitals & Clinics Case Studies
    Figure 9. Academic & Research Institutes Case Studies
    Figure 10. Type-1 Diabetes Treatment Report Years Considered
    Figure 11. Global Type-1 Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Type-1 Diabetes Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Type-1 Diabetes Treatment Market Share by Region: 2022 VS 2029
    Figure 14. Global Type-1 Diabetes Treatment Market Share by Players in 2022
    Figure 15. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2022
    Figure 17. North America Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Type-1 Diabetes Treatment Market Share by Country (2018-2029)
    Figure 19. United States Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Type-1 Diabetes Treatment Market Share by Country (2018-2029)
    Figure 23. Germany Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Type-1 Diabetes Treatment Market Share by Region (2018-2029)
    Figure 31. China Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Type-1 Diabetes Treatment Market Share by Country (2018-2029)
    Figure 39. Mexico Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Type-1 Diabetes Treatment Market Share by Country (2018-2029)
    Figure 43. Turkey Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 46. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 47. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 48. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 49. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 50. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 51. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 52. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 53. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 54. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 55. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 56. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 57. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Astellas Pharma
Merck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.
Frequently Asked Questions
Type-1 Diabetes Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Type-1 Diabetes Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Type-1 Diabetes Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Stoma or Ostomy Care

This report aims to provide a comprehensive presentation of the global market for Stoma or Ostomy ... Read More

Data Classification

This report aims to provide a comprehensive presentation of the global market for Data Classifica ... Read More